96987 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Prolactin
ANTAGONIST FUSION POLYPEPTIDES
#2DOMINANT NEGATIVE LIGAND CHIMERIC ANTIGEN RECEPTOR SYSTEMS
#3Immunomodulatory polypeptides and related compositions and methods
#4COMPOSITIONS AND METHODS FOR IDENTIFYING ENZYME MODULATORS OR INHIBITORS
#5Methods of treating PRLR positive breast cancer
#6COMPOSITIONS AND METHODS FOR IDENTIFYING ENZYME MODULATORS OR INHIBITORS
#7Recombinant DNA Vectors for Expression of Human Prolactin Antagonists
#8Novel Prolactin Compounds
#9Peptides with high affinity for the prolactin receptor
#10N-Terminal Pegylated Prolactin Receptor Molecules
#11Peptides with High Affinity for the Prolactin Receptor
#12Methods and compositions for improved fertilization and embryonic survival
#13Human prolactin antagonist-angiogenesis inhibitor fusion proteins
#14USE OF CELL IMPLANTS IN BLADDER AND GUT OF NON-HUMAN ANIMALS FOR THE PRODUCTION OF PEPTIDES
#15Novel Antiangiogenic Peptide Agents and Their Therapeutic and Diagnostic Use
#16Novel Antiangiogenic Peptide Agents and Their Therapeutic and Diagnostic Use
#17Antiangiogenic peptides
#18GENES ASSOCIATED WITH OBESITY AND METHODS FOR USING THE SAME
#19Variants of mammalian prolactin, prolactin receptor antagonists, and methods of use
#20Antagonists for human prolactin
#21Antagonists for human prolactin
#22Genes associated with obesity and methods for using the same